A Bacillus subtilis fusion protein system to produce soybean Bowman-Birk protease inhibitor

Protein Expression and Purification

Volumn 55, Issue 1, 2007, Pages 40-52

  Vogtentanz, Gudrun ^a   Collier, Katherine D ^a   Bodo, Michael ^a   Chang, Judy H ^a   Day, Anthony G ^a   Estell, David A ^a   Falcon, Brandy C ^a   Ganshaw, Grant ^a   Jarnagin, Alisha S ^a   Kellis Jr , James T ^a   Kolkman, Marc A B ^b   Lai, Cindy S ^a   Meneses, Renato ^a   Miller, Jeffrey V ^a   Nobel, Hans de ^b   Power, Scott ^a   Weyler, Walter ^a   Wong, David L ^a   Schmidt, Brian F ^a  

^a GENENCOR INTERNATIONAL INC   (United States)

^b Genencor International BV   (Netherlands)

Author keywords

Acid cleavage; Bacillus subtilis; BBI; Bowman Birk; Cellulase; Fusion protein; Protease inhibitor; Proteinase inhibitor; Recombinant

Indexed keywords

BOWMAN BIRK INHIBITOR; CELLULASE; GLUTAMYL ENDOPEPTIDASE; HYBRID PROTEIN; SERINE PROTEINASE; SUBTILISIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACILLUS SUBTILIS; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PROMOTER REGION;

AMINO ACID SEQUENCE; BACILLUS SUBTILIS; CELLULASE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; SERINE ENDOPEPTIDASES; SUBTILISINS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

BACILLUS SP.; BACILLUS SUBTILIS; GLYCINE MAX; POSIBACTERIA;

EID: 34547930744     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.05.001     Document Type: Article

References (62)

1. Prakash B., Selvaraj S., Murthy M.R.N., Sreerama Y.N., Rao D.R., and Gowda L.R. Analysis of the amino acid sequences of plant Bowman-Birk inhibitors. J. Mol. Evol. 42 (1996) 560-569
2. Mello M.O., Tanaka A.S., and Silva-Filho M.C. Molecular evolution of Bowman-Birk type proteinase inhibitors in flowering plants. Mol. Phylogenet. Evol. 27 (2003) 103-112
3. Qi R.F., Song Z.W., and Chi C.W. Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application. Acta Biochim. Biophys. Sin. (Shanghai) 37 (2005) 283-292
4. Birk Y. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans. Int. J. Pept. Protein Res. 25 (1985) 113-131
5. Odani S., Koide T., and Ikenaka T. Studies on soybean trypsin inhibitors. 3. Isolation and sequence determination of the tryptic peptides of Bowman-Birk soybean proteinase inhibitor. J. Biochem. (Tokyo) 71 (1972) 831-838
6. Hammond R.W., Foard D.E., and Larkins B.A. Molecular cloning and analysis of a gene coding for the Bowman-Birk protease inhibitor in soybean. J. Biol. Chem. 259 (1984) 9883-9890
7. Baek J.M., and Kim S.I. Nucleotide sequence of a cDNA encoding soybean Bowman-Birk proteinase inhibitor. Plant Physiol. 102 (1993) 687
8. Koepke J., Ermler U., Warkentin E., Wenzl G., and Flecker P. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 Å resolution. Structural basis of Janus-faced serine protease inhibitor specificity. J. Mol. Biol. 298 (2000) 477-491
9. Kennedy A.R. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am. J. Clin. Nutr. 68 Suppl. (1998) 1406S-1412S
10. Lippman S.M., and Matrisian L.M. Protease inhibitors in oral carcinogenesis and chemoprevention. Clin. Cancer Res. 6 (2000) 4599-4603
11. Armstrong W.B., Kennedy A.R., Wan X.S., Taylor T.H., Nguyen Q.A., Jensen J., Thompson W., Lagerberg W., and Meyskens Jr. F.L. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin. Cancer Res. 6 (2000) 4684-4691
12. Armstrong W.B., Wan X.S., Kennedy A.R., Taylor T.H., and Meyskens Jr. F.L. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. Laryngoscope 113 (2003) 1687-1702
13. Dittmann K.H., Mayer C., and Rodemann H.P. Radioprotection of normal tissue to improve radiotherapy: the effect of the Bowman Birk protease inhibitor. Curr. Med. Chem. Anticancer Agents 3 (2003) 360-363
14. Morris C.A., Morris L.D., Kennedy A.R., and Sweeney H.L. Attenuation of skeletal muscle atrophy via protease inhibition. J. Appl. Physiol. 99 (2005) 1719-1727
15. Brauer A.B.E., Kelly G., McBride J.D., Cooke R.M., Matthews S.J., and Leatherbarrow R.J. The Bowman-Birk inhibitor reactive site loop sequence represents an independent structural beta-hairpin motif. J. Mol. Biol. 306 (2001) 799-807
16. McBride J.D., and Leatherbarrow R.J. Synthetic peptide mimics of the Bowman-Birk inhibitor protein. Curr. Med. Chem. 8 (2001) 909-917
17. McBride J.D., Freeman H.N.M., and Leatherbarrow R.J. Selection of human elastase inhibitors from a conformationally constrained combinatorial peptide library. Eur. J. Biochem. 266 (1999) 403-412
18. Flecker P. Chemical synthesis, molecular cloning and expression of gene coding for a Bowman-Birk-type proteinase inhibitor. Eur. J. Biochem. 166 (1987) 151-156
19. Philipp S., Kim Y.M., Dürr I., Wenzl G., Vogt M., and Flecker P. Mutational analysis of disulfide bonds in the trypsin-reactive subdomain of a Bowman-Birk-type inhibitor of trypsin and chymotrypsin. Cooperative versus autonomous refolding of subdomains. Eur. J. Biochem. 251 (1998) 854-862
20. Yakoby N., and Raskin I. A simple method to determine trypsin and chymotrypsin inhibitory activity. J. Biochem. Biophys. Methods 59 (2004) 241-251
21. Li W., Zhou X., and Lu P. Bottlenecks in the expression and secretion of heterologous proteins in Bacillus subtilis. Res. Microbiol. 155 (2004) 605-610
22. Schallmey M., Singh A., and Ward O.P. Developments in the use of Bacillus species for industrial production. Can. J. Microbiol. 50 (2004) 1-17
23. Westers L., Westers H., and Quax W.J. Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim. Biophys. Acta 1694 (2004) 299-310
24. E. Ferrari, C. Harbison, M.H. Rashid, W. Weyler, Enhanced protein expression in Bacillus, US Patent Application Publication 20060073559A1, Genencor International, Inc., USA, 2006.
25. Wu X.C., Lee W., Tran L., and Wong S.L. Engneering a Bacillus subtilis expression secretion system with a strain deficient in six extracellular proteases. J. Bacteriol. 173 (1991) 4952-4958
26. Hahn J., Luttinger A., and Dubnau D. Regulatory inputs for the synthesis of ComK, the competence transcription factor of Bacillus subtilis. Mol. Microbiol. 21 (1996) 763-775
27. Anagnostopoulos C., and Spizizen J. Requirements for transformation in Bacillus subtilis. J. Bacteriol. 81 (1961) 741-746
28. Flecker P. A new and general procedure for refolding mutant Bowman-Birk-type proteinase inhibitors on trypsin-Sepharose as a matrix with complementary structure. FEBS Lett. 252 (1989) 153-157
29. Kakudo S., Kikuchi N., Kitadokoro K., Fujiwara T., Nakamura E., Okamoto H., Shin M., Tamaki M., Teraoka H., Tsuzuki H., and Yoshida N. Purification, characterization, cloning, and expression of a glutamic acid-specific protease from Bacillus licheniformis ATCC 14580. J. Biol. Chem. 267 (1992) 23782-23788
30. Svendsen I., and Breddam K. Isolation and amino acid sequence of a glutamic acid specific endopeptidase from Bacillus licheniformis. Eur. J. Biochem. 204 (1992) 165-171
31. Yuuki T., Nomura T., Tezuka H., Tsuboi A., Yamagata H., Tsukagoshi N., and Udaka S. Complete nucleotide sequence of a gene coding for heat- and pH-stable alpha-amylase of Bacillus licheniformis: comparison of the amino acid sequences of three bacterial liquefying alpha-amylases deduced from the DNA sequences. J. Biochem. (Tokyo) 98 (1985) 1147-1156
32. P.V. Soligen, Alkaline cellulase and method of producing same. US Patent 6063611, Genencor International Inc., USA, 2000.
33. Shaw A., Bott R., Vonrhein C., Bricogne G., Power S., and Day A.G. A novel combination of two classic catalytic schemes. J. Mol. Biol. 320 (2002) 303-309
34. Perego M. Integrational vectors for genetic manipulation in Bacillus subtilis. In: Sonenshein A.L., Hoch J.A., and Losick R. (Eds). Bacillus subtilis and other Gram-Positive Bacteria: Biochemistry, Physiology, and Molecular Genetics (1993), American Society for Microbiology, Washington, DC 615-624
35. Babé L.M., Yoast S., Dreyer M., and Schmidt B.F. Heterologous expression of human granzyme K in Bacillus subtilis and characterization of its hydrolytic activity in vitro. Biotechnol. Appl. Biochem. 27 (1998) 117-124
36. Neidhardt F.C., Bloch P.L., and Smith D.F. Culture medium for enterobacteria. J. Bacteriol. 119 (1974) 736-747
37. Westers L., Dijkstra D.S., Westers H., van Dijl J.M., and Quax W.J. Secretion of functional human interleukin-3 from Bacillus subtilis. J. Biotechnol. 123 (2006) 211-224
38. van Tilbeurgh H., Loontiens F.G., de Bruyne C.K., and Claeyssens M. Fluorogenic and chromogenic glycosides as substrates and ligands of carbohydrases. Meth. Enzymol. 160 (1988) 45-59
39. Valle F., and Ferrari E. Subtilisin: a redundantly temporally regulated gene. In: Smith I., Slepecky A.R., and Setlow P. (Eds). Regulation of Prokaryotic Development (1989), American Society for Microbiology, Washington, DC 131-146
40. Berkmen M., Boyd D., and Beckwith J. The nonconsecutive disulfide bond of Escherichia coli phytase (AppA) renders it dependent on the protein-disulfide isomerase, DsbC. J. Biol. Chem. 280 (2005) 11387-11394
41. Lian Q., Szarka S.J., Ng K.K.S., and Wong S.L. Engineering of a staphylokinase-based fibrinolytic agent with antithrombotic activity and targeting capability toward thrombin-rich fibrin and plasma clots. J. Biol. Chem. 278 (2003) 26677-26686
42. Landon M. Cleavage at aspartyl-prolyl bonds. Meth. Enzymol. 47 (1977) 145-149
43. Lamed R., Kenig R., Morag E., Yaron S., Shoham Y., and Bayer E.A. Nonproteolytic cleavage of aspartyl proline bonds in the cellulosomal scaffoldin subunit from Clostridium thermocellum. Appl. Biochem. Biotechnol. 90 (2001) 67-73
44. Stennicke H.R., and Breddam K. 440.Glutamyl endopeptidase I. In: Barret A.J., Rawlings N.D., and Woessner J.F. (Eds). Handbook of Proteolytic Enzymes Vol. 2: Cysteine Serine and Threonine Peptidases (2004), Elsevier Academic Press, Amsterdam 1448-1451
45. Wu S.C., Yeung J.C., Duan Y., Ye R., Szarka S.J., Habibi H.R., and Wong S.L. Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production. Appl. Environ. Microbiol. 68 (2002) 3261-3269
46. McGrath M.E., Osawa A.E., Barnes M.G., Clark J.M., Mortara K.D., and Schmidt B.F. Production of crystallizable human chymase from a Bacillus subtilis system. FEBS Lett. 413 (1997) 486-488
47. Wu S.C., Castellino F.J., and Wong S.L. A fast-acting, modular-structured staphylokinase fusion with Kringle-1 from human plasminogen as the fibrin-targeting domain offers improved clot lysis efficacy. J. Biol. Chem. 278 (2003) 18199-18206
48. van Wely K.H.M., Swaving J., Freudl R., and Driessen A.J.M. Translocation of proteins across the cell envelope of Gram-positive bacteria. FEMS Microbiol. Rev. 25 (2001) 437-454
49. Sarvas M., Harwood C.R., Bron S., and van Dijl J.M. Post-translocational folding of secretory proteins in Gram-positive bacteria. Biochim. Biophys. Acta 1694 (2004) 311-327
50. Bolhuis A., Venema G., Quax W.J., Bron S., and van Dijl J.M. Functional analysis of paralogous thiol-disulfide oxidoreductases in Bacillus subtilis. J. Biol. Chem. 274 (1999) 24531-24538
51. Miyauchi A., Ozawa M., Mizukami M., Yashiro K., Ebisu S., Tojo T., Fujii T., and Takagi H. Structural conversion from non-native to native form of recombinant human epidermal growth factor by Brevibacillus choshinensis. Biosci. Biotechnol. Biochem. 63 (1999) 1965-1969
52. Tanaka R., Mizukami M., Ishibashi M., Tokunaga H., and Tokunaga M. Cloning and expression of the ccdA-associated thiol-disulfide oxidoreductase (catA) gene from Brevibacillus choshinensis: stimulation of human epidermal growth factor production. J. Biotechnol. 103 (2003) 1-10
53. LaVallie E.R., and McCoy J.M. Gene fusion expression systems in Escherichia coli. Curr. Opin. Biotechnol. 6 (1995) 501-506
54. Sorensen H.P., and Mortensen K.K. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 115 (2005) 113-128
55. Waugh D.S. Making the most of affinity tags. Trends Biotechnol. 23 (2005) 316-320
56. M.D. Rasmussen, M.E. Bjoernvad, I. Diers, Pectate lyase fusion for expression and secretion of polypeptides, European Patent EP1187925B1, Novozymes, Denmark, 2005.
57. Olmos-Soto J., and Contreras-Flores R. Genetic system constructed to overproduce and secrete proinsulin in Bacillus subtilis. Appl. Microbiol. Biotechnol. 62 (2003) 369-373
58. Kajino T., Ohto C., Muramatsu M., Obata S., Udaka S., Yamada Y., and Takahashi H. A protein disulfide isomerase gene fusion expression system that increases the extracellular productivity of Bacillus brevis. Appl. Environ. Microbiol. 66 (2000) 638-642
59. Wu S.C., Ye R., Wu X.C., Ng S.C., and Wong S.L. Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones. J. Bacteriol. 180 (1998) 2830-2835
60. Lam K.H.E., Chow K.C., and Wong W.K.R. Construction of an efficient Bacillus subtilis system for extracellular production of heterologous proteins. J. Biotechnol. 63 (1998) 167-177
61. Sagiya Y., Yamagata H., and Udaka S. Direct high-level secretion into the culture medium of tuna growth hormone in biologically active form by Bacillus brevis. Appl. Microbiol. Biotechnol. 42 (1994) 358-363
62. Shiga Y., Maki M., Ohta T., Tokishita S., Okamoto A., Tsukagoshi N., Udaka S., Konishi A., Kodama Y., Ejima D., Matsui H., and Yamagata H. Efficient production of N-terminally truncated biologically active human interleukin-6 by Bacillus brevis. Biosci. Biotechnol. Biochem. 64 (2000) 665-669